| Li, Xu |
NCT06736860: Tranexamic Acid in Patients With Traumatic Bleeding Based on Dynamic Monitoring of Thromboelastography |
|
|
| Recruiting | 4 | 580 | RoW | Tranexamic acid (TXA) injection | Nanfang Hospital, Southern Medical University | Trauma Coagulopathy | 10/27 | 12/28 | | |
| Not yet recruiting | 4 | 778 | NA | Nafamostat mesilate, 5% glucose | Xu Li, Tianjin Third Central Hospital, Tianjin Medical University General Hospital, Shanxi Provincial People's Hospital, Shanxi Bethune Hospital, Hohhot First Hospital, The First Bethune Hospital Jilin University, Northern Jiangsu Province People's Hospital, The Affiliated Hospital of Nantong University, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, The First Affiliated Hospital of Suzhou Medical, Anhui Provincial Hospita, Zhejiang Hospital, Zhejiang Provincial People's Hospital, The First Affiliated Hospital of Ningbo, The First Affiliated Hospital of Wenzhou, The Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Gannan Medical University, The Second Affiliated Hospital Xi'an Jiaotong, LanZhou University, The First Affiliated Hospital of Xinjiang, First Affiliated Hospital of Xinjiang Medical University, Tongji Medical College of Huazhong University, The Second Hospital University of South China, The Fourth Affiliated Hospital of China Medical, The First Affiliated Hospital of Liaoning, Genertec Liaoyou Gem Flower Hospital, The Tenth People's Hospital of Shenyang, The Sixth People's Hospital of Shenyang, Dalian NO.3 People's Hospital, Benxi Cental Hospital, Liaoyang City Central Hospital, Huludao central hospital | Sepsis, Sepsis-induced Coagulopathy, Nafamostat Mesilate | 10/26 | 10/26 | | |
NCT05664750: Study to Compare the Efficacy and Safety of Passive Immunization With TNM002 Injection and Human Tetanus Immunoglobulin as Prophylaxis Against Tetanus |
|
|
| Completed | 3 | 675 | RoW | TNM002, Human tetanus immunoglobulin (HTIG) | Zhuhai Trinomab Pharmaceutical Co., Ltd. | Tetanus | 03/23 | 07/23 | | |
NCT05439629: Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Macular Degeneration |
|
|
| Active, not recruiting | 3 | 488 | RoW | BAT5906 injection, Lucentis | Bio-Thera Solutions | Neovascular (Wet) Age-related Macular Degeneration | 04/24 | 06/25 | | |
NCT06355258: A Study of the Efficacy of Troxerutin in Preventing Thrombotic Events in COVID-19 Patients |
|
|
| Recruiting | 1 | 80 | RoW | Troxerutin, Placebo, placebo + low molecular weight heparin, troxerutin + low molecular weight heparin | Westlake University, Shaoxing Central Hospital, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University | COVID 19 Associated Coagulopathy | 12/24 | 03/25 | | |
NCT05689125: Bougies as Aid for Endotracheal Intubation Via Video Laryngoscopy During Continuous Chest Compressions |
|
|
| Completed | N/A | 65 | RoW | Railroaded bougie, Preloaded bougie, Stylet | Peking Union Medical College Hospital | Endotracheal Intubation, Cardiopulmonary Resuscitation, Simulation | 02/23 | 02/23 | | |
| Sun, Xiaonan |
| Terminated | 3 | 166 | Europe, Canada, Japan, US, RoW | Xevinapant (Debio 1143), IMRT, Placebo | EMD Serono Research & Development Institute, Inc., Merck KGaA, Darmstadt, Germany | Head and Neck Cancer | 08/24 | 08/24 | | |
NCT06717152: Efficacy and Safety of SJP-0132 Eye Drops in Chinese Patients With Dry Eye Disease |
|
|
| Recruiting | 3 | 400 | RoW | SJP-0132, Placebo | Senju Pharmaceutical Science & Technology (Beijing) Co., Ltd., Senju Pharmaceutical Co., Ltd. | Dry Eye | 07/25 | 08/25 | | |
NCT06433830: Hetrombopag for the Thrombocytopenia Induced by Concurrent Chemoradiotherapy |
|
|
| Recruiting | 2 | 50 | RoW | Hetrombopag Olamine, thrombopoietin receptor agonist | Sir Run Run Shaw Hospital | Thrombocytopenia, Radiotherapy Side Effect | 05/25 | 07/25 | | |
NCT05145907: Study to Evaluate Safety and Efficacy of TJ107 Combine With PD-1 in Patients With Solid Tumors |
|
|
| Active, not recruiting | 2 | 133 | RoW | TJ107 +Pembrolizumab | TJ Biopharma Co., Ltd. | Triple-negative Breast Cancer, Head and Neck Squamous Cell Carcinoma | 06/24 | 12/24 | | |
NCT06434740: A Study of SBRT Combined With Puterizumab in Intrapulmonary Metastasis From NSCLC |
|
|
| Not yet recruiting | 2 | 37 | NA | Stereotactic Body Radiation Therapy，SBRT, Puterizumab | Sir Run Run Shaw Hospital | Non-Small-Cell Lung Cancer | 12/26 | 12/27 | | |
| Li, Peijun |
NCT05188989: Efficacy and Safety Study of TPN171H Tablets in Erectile Dysfunction. |
|
|
| Completed | 3 | 765 | RoW | TPN171H 2.5mg group, Simmerafil, TPN171H 5mg group, TPN171H 10mg group, Placebo group | Vigonvita Life Sciences | Erectile Dysfunction | 02/23 | 02/23 | | |
nAMD, NCT05461339: TAB014 Compared to Lucentis® in Patients with Neovascular Age-related Macular Degeneration |
|
|
| Active, not recruiting | 3 | 488 | RoW | TAB014 Monoclonal Antibody Injection, TAB014, Ranibizumab Injection [Lucentis], Lucentis | TOT Biopharm Co., Ltd., Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. | Neovascular Age-related Macular Degeneration | 09/24 | 02/25 | | |
| Gong, Lan |
NCT06717152: Efficacy and Safety of SJP-0132 Eye Drops in Chinese Patients With Dry Eye Disease |
|
|
| Recruiting | 3 | 400 | RoW | SJP-0132, Placebo | Senju Pharmaceutical Science & Technology (Beijing) Co., Ltd., Senju Pharmaceutical Co., Ltd. | Dry Eye | 07/25 | 08/25 | | |
